R. G. Bristow and R. P. Hill, Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability, Nat Rev Cancer, vol.8, pp.180-92, 2008.

A. Turaka, M. K. Buyyounouski, A. L. Hanlon, E. M. Horwitz, R. E. Greenberg et al., Hypoxic prostate/muscle PO2 ratio predicts for outcome in patients with localized prostate cancer: long-term results, Int J Radiat Oncol Biol Phys, vol.82, pp.433-442, 2012.

M. Milosevic, W. P. Menard, C. Chung, P. Toi, A. Ishkanian et al., Tumor hypoxia predicts biochemical failure following radiotherapy for clinically localized prostate cancer, Clin Cancer Res, vol.18, pp.2108-2122, 2012.

R. Vergis, C. M. Corbishley, A. R. Norman, J. Bartlett, S. Jhavar et al., Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study, Lancet Oncol, vol.9, pp.342-51, 2008.

E. Lalonde, A. S. Ishkanian, J. Sykes, M. Fraser, H. Ross-adams et al., Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study, Lancet Oncol, vol.15, pp.1521-1553, 2014.

S. Supiot, C. Rousseau, M. Dore, C. Cheze-le-rest, C. Kandel-aznar et al., Evaluation of tumor hypoxia prior to radiotherapy in intermediate-risk prostate cancer using (18)F-fluoromisonidazole PET/CT: a pilot study, Oncotarget, vol.9, pp.10005-10020, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-01823478

I. C. Mainta, T. Zilli, J. C. Tille, D. Perrot, T. Vallee et al., The effect of neoadjuvant androgen deprivation therapy on tumor hypoxia in high-grade prostate cancer: an (18)F-MISO PET-MRI Study, Int J Radiat Oncol Biol Phys, 2018.

J. S. Rasey, W. J. Koh, M. L. Evans, L. M. Peterson, T. K. Lewellen et al., Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients, Int J Radiat Oncol Biol Phys, vol.36, pp.417-445, 1996.

D. Thorwarth, M. Notohamiprodjo, D. Zips, and A. C. Muller, Personalized precision radiotherapy by integration of multi-parametric functional and biological imaging in prostate cancer: A feasibility study, Z Med Phys, vol.27, pp.21-30, 2017.

V. A. Potiron, R. Abderrahmani, K. Clement-colmou, S. Marionneau-lambot, T. Oullier et al., Improved functionality of the vasculature during conventionally fractionated radiation therapy of prostate cancer, PLoS One, vol.8, p.84076, 2013.

H. E. Barker, J. T. Paget, A. A. Khan, and K. J. Harrington, The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence, Nat Rev Cancer, vol.15, pp.409-434, 2015.

S. Supiot, A. Lisbona, F. Paris, D. Azria, and P. Fenoglietto, Dose-painting": myth or reality?, Cancer Radiother, vol.14, pp.554-62, 2010.

J. M. Martin, S. Supiot, and D. R. Berthold, Pharmacotherapeutic management of locally advanced prostate cancer: current status, Drugs, vol.71, pp.1019-1060, 2011.

C. N. Catton, H. Lukka, C. S. Gu, J. M. Martin, S. Supiot et al., Randomized trial of a hypofractionated radiation regimen for the treatment of localized prostate cancer, J Clin Oncol, vol.35, pp.1884-90, 2017.

M. Hatt, C. Le-rest, C. Descourt, P. Dekker, A. De-ruysscher et al., Accurate automatic delineation of heterogeneous functional volumes in positron emission tomography for oncology applications, Int J Radiat Oncol Biol Phys, vol.77, pp.301-309, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00537776

M. Hatt, C. Le-rest, and C. , A fuzzy locally adaptive Bayesian segmentation approach for volume determination in PET, IEEE Trans Med Imag, vol.28, pp.881-93, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00372910

M. Milosevic, P. Chung, C. Parker, R. Bristow, A. Toi et al., Androgen withdrawal in patients reduces prostate cancer hypoxia: implications for disease progression and radiation response, Cancer Res, vol.67, pp.6022-6027, 2007.

I. C. Mainta, T. Zilli, J. C. Tille, D. Perrot, T. Vallee et al., The effect of neoadjuvant androgen deprivation therapy on tumor hypoxia in high-grade prostate cancer: an (18)F-MISO PET-MRI study, Int J Radiat Oncol Biol Phys, vol.102, pp.1210-1218, 2018.

S. M. Eschmann, F. Paulsen, C. Bedeshem, H. J. Machulla, T. Hehr et al., Hypoxia-imaging with (18)F-Misonidazole and PET: changes of kinetics during radiotherapy of head-and-neck cancer, Radiother Oncol, vol.83, pp.406-416, 2007.

D. Zips, K. Zophel, N. Abolmaali, R. Perrin, A. Abramyuk et al., Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer, Radiother Oncol, vol.105, pp.21-29, 2012.

W. D. Foltz, A. Wu, P. Chung, C. Catton, A. Bayley et al., Changes in apparent diffusion coefficient and T2 relaxation during radiotherapy for prostate cancer, J Magn Reson Imaging, vol.37, pp.909-925, 2013.

R. Garcia-parra, D. Wood, R. B. Shah, J. Siddiqui, H. Hussain et al., Investigation on tumor hypoxia in resectable primary prostate cancer as demonstrated by 18F-FAZA PET/CT utilizing multimodality fusion techniques, Eur J Nucl Med Mol Imaging, vol.38, pp.1816-1839, 2011.